Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.

Abbotsford, Joanne; Foley, David A; Goff, Zoy; Bowen, Asha C; Blyth, Christopher C; Yeoh, Daniel K

Abbotsford, Joanne; Foley, David A; Goff, Zoy; Bowen, Asha C; Blyth, Christopher C; Yeoh, Daniel K.

Afiliação

Abbotsford J; Department of Infectious Diseases, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Foley DA; Department of Infectious Diseases, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Goff Z; Department of Infectious Diseases, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Bowen AC; Department of Infectious Diseases, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Blyth CC; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia.
Yeoh DK; University of Western Australia, School of Medicine, Perth, Western Australia, Australia.

J Antimicrob Chemother ; 76(1): 249-252, 2021 01 01.

Article em En | MEDLINE | ID: mdl-32929460

Assuntos

Aspergilose Broncopulmonar Alérgica; Itraconazol; Adulto; Antifúngicos/uso terapêutico; Aspergilose Broncopulmonar Alérgica/tratamento farmacológico; Criança; Hospitais Pediátricos; Humanos; Itraconazol/uso terapêutico; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspergilose Broncopulmonar Alérgica / Itraconazol Tipo de estudo: Guideline / Observational_studies Limite: Adult / Child / Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google